BioWorld

Dec. 8, 2008

Deerfield Counters Proposed NitroMed-Archemix Merger

NitroMed Inc. shareholder Deerfield Management is less than thrilled with the company's plan to serve as a public shell for a reverse merger with privately held Archemix Corp. (BioWorld Today) Read More

Stupak Urges Obama to Go Outside the FDA for New Chief

Study Shows How Gene Variation Affects Anemia

ISTA's Phase III Eye Drug Study Region Showed Skewed Results

Departing Execs, Halted Trials Send Orexigen Shares Falling

Other News To Note

Clinic Roundup

Appointments And Advancements

Financings Roundup

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 27, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Muted and missing M&As: JPM deals absent in 2026

BioWorld

For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...